Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
06/2003
06/18/2003CN1425016A Benzoxathiepino [3,4-b] pyridine derivatives, process for their preparation and their use as medicaments
06/18/2003CN1424999A Aminoalcohol derivatives
06/18/2003CN1424910A IL-8 receptor antagonists
06/18/2003CN1424043A Kakonein eye drops
06/18/2003CN1424030A Medicines for preventing and treating retina and cornea blood vessel diseases
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111528C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/17/2003US6579983 5-cyano-2-aminopyrimidine derivatives
06/17/2003US6579982 Treating inflammation, cancer
06/17/2003US6579902 Antibiotic; ethoxy-carbamic acid 3'-ester of N-(7-((6-deoxy-5-C-methyl-4-O- methyl-alpha-L-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-1 -benzopyran-3-yl)-benzeneacetamide
06/17/2003US6579901 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
06/17/2003US6579900 Can be used to reduce pain, reducing nausea in an individual undergoing chemotherapy, suppressing appetite, reducing intraocular pressure, and suppressing the immune system in an individual with an organ transplant.
06/17/2003US6579896 Method for treating allergies using substituted pyrazoles
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/17/2003US6579874 Substituted azoles
06/17/2003US6579700 Neuropeptide Y (NPY); isolated peptide of given amino acid sequence; may be useful in regulating central and peripheral nervous and endocrine systems
06/17/2003CA2198245C Methods and means for drug administration
06/14/2003CA2364985A1 Imidazo(2,1-b)thiadiazole sulfonamides
06/12/2003WO2003048192A1 Novel peptides and medicinal uses thereof
06/12/2003WO2003048180A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003048120A2 2-aryl pyrrologpyrimidines for a1 and a3 receptors
06/12/2003WO2003048117A2 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
06/12/2003WO2003048116A2 Esters and amides as ppar-alpha agonists ____________
06/12/2003WO2003047633A2 Treatment of angiogenesis disorders using targeted nanoparticles
06/12/2003WO2003047618A2 Immunotherapeutic methods and systems
06/12/2003WO2003047597A1 Combination of crystalline form of a ribofuranosyluronamide derivative and tiotropium salt
06/12/2003WO2003047588A1 Kit for reducing aching caused by pde-v inhibitors
06/12/2003WO2003047577A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
06/12/2003WO2003047559A1 Use of polycyclic phenolic compounds for the treatment of opthalmic diseases
06/12/2003WO2003047554A1 Transdermal drug delivery system of strychnine, brucine, securinine and their salts
06/12/2003WO2003047521A2 Composition and method for treatment of otitis media
06/12/2003WO2003047513A2 Method for treating ocular hypertension
06/12/2003WO2003047500A2 Vaccine and method for treatment of motor neurone diseases
06/12/2003WO2003047417A2 Ep4 receptor agonist, compositions and methods thereof
06/12/2003WO2001071007A3 GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF
06/12/2003US20030109671 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
06/12/2003US20030109566 Therapeutic treatment of diseases in optic nerve and the like.
06/12/2003US20030109545 Their solvates and/or hydrates exhibiting an affinity and a selectivity for arginine-vasopressin V1b receptors or for both V1b and V1a receptors.
06/12/2003US20030109522 Ophthalmologic treatment methods using selective iNOS inhibitors
06/12/2003US20030109516 Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof
06/12/2003US20030109509 Methods for treating dry eye
06/12/2003US20030109508 Administering fixed combinations of MUC-1 secretagogues, such as HETE derivatives, and androgen compounds are disclosed.
06/12/2003US20030109488 Methods for treating dry eye
06/12/2003US20030109452 Containing phenylalanine, leucine, alanine, and lysine residues are disclosed. The peptides can be used in antibacterial, antifungal, anticancer, and other biological applications.
06/12/2003US20030109439 Keratinocyte growth factor (KGF) polypeptides and methods of using the same are described. The KGF polypeptides of the present invention display enhanced bioactivity relative to full-length KGF163 in lower concentrations
06/12/2003US20030109437 Peptides and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such
06/12/2003US20030109429 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
06/12/2003US20030109422 Process for the preparation of pharmaceutical formulations containing lactoferrin
06/12/2003US20030108540 Inducing apoptosis in tissues; binding antibodies
06/12/2003US20030108539 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
06/12/2003US20030108496 Compositions comprising phenyl-glycine derivatives
06/12/2003CA2469227A1 New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
06/12/2003CA2469134A1 Novel peptide and pharmaceutical use of the same
06/12/2003CA2469092A1 Copolymer 1 vaccine and methods for treatment of amyotrophic lateral sclerosis (als)
06/12/2003CA2469078A1 Immunotherapeutic methods and systems
06/12/2003CA2468342A1 Use of polycyclic phenolic compounds for the treatment of opthalmic diseases
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003CA2466757A1 Method for treating ocular hypertension
06/12/2003CA2466751A1 Ep4 receptor agonist, compositions and methods thereof
06/11/2003EP1318150A1 Novel crystals of 1,3,4-oxadiazole derivative, process for producing the crystals and medicines containing the same as the active ingredient
06/11/2003EP1318149A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing them
06/11/2003EP1317924A1 Kit for reducing aching caused by pde-v inhibitors
06/11/2003EP1317465A1 Purine derivatives
06/11/2003EP1317454A2 Caspase inhibitors and uses thereof
06/11/2003EP1317428A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors
06/11/2003EP1317421A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317420A1 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317417A2 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317283A2 Tweak receptor agonists as anti-angiogenic agents
06/11/2003EP1317280A2 Vaccine against streptococcus pneumoniae
06/11/2003EP1317279A2 Vaccine against streptococcus pneumoniae
06/11/2003EP1317269A2 Composition containing a 15-keto prostaglandin compound for treating of ocular hypertension and glaucoma
06/11/2003EP1317264A2 Combination of lipoic acids and conjugated acids for treating diabetic disorders
06/11/2003EP1317259A2 Prevention of acute sinusitis and sinus attack
06/11/2003EP1060161B1 Matrix metalloproteinase inhibitors
06/11/2003EP1024810A4 Method for optimizing retinal and optic nerve health
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex
06/11/2003CN1423693A Method for the production of vitamin A
06/11/2003CN1423647A Beta-alanine derivatives and their use as receptor antagonists
06/11/2003CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
06/11/2003CN1423645A 维他命d类似物 Vitamin d analogues
06/11/2003CN1423638A Ox (adi) azolyl-hydroxamic acids useful as procollagen C-proteinase inhibitors
06/11/2003CN1423633A Azetidine derivatives, preparation thereof and pharmaceutical compositions
06/11/2003CN1423627A 维生素d类似物 Vitamin d analogues
06/11/2003CN1423562A Perfusion liquid preparations for ophthalmic operations
06/11/2003CN1111050C Chinese medicine for curing streptomycin toxic deafness
06/11/2003CN1111047C Cassia seed tea and its preparing process
06/10/2003US6576762 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
06/10/2003US6576745 Human cystatin F antibodies
06/10/2003US6576653 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
06/10/2003US6576649 Method for treating pharmaceutical compositions
06/10/2003US6576644 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
06/10/2003US6576641 For therapy and prophylaxis of Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), or a neurodegenerative disease of the eye, including photoreceptor loss in retina
06/10/2003US6576640 Rapidly penetration into central nervous system; treating noradrenaline deficiency; depression, Parkinson's disease
06/10/2003US6576613 Title inhibitors of urokinase
06/06/2003CA2413479A1 Kit for reducing aching
06/05/2003WO2003045951A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
1 ... 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 ... 531